Similarly, Hong and colleagues showed that Wnt/β-catenin activity in BCSCs (ALDH1 positive) is significantly higher than in bulk cancer cells, and that blockade of Wnt/β-catenin signaling suppresses CSC-like phenotypes in a mouse model of breast cancer (Jang et al., 2015a). Here, ALDH1A1 is linked to breast carcinoma.